Nasenspray-Ratiopharm® Erwachsene (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasenspray-Ratiopharm® Erwachsene, is an imidazoline nasal decongestant presented as a nasal spray for nasal use. It treats nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults.

GNH USA supplies Nasenspray-Ratiopharm® Erwachsene as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride acts locally on the nasal mucosa to relieve congestion in several common upper‑respiratory conditions.

- Common cold: reduces swelling of nasal passages and eases breathing. - Sinusitis: alleviates sinus‑related nasal blockage. - Allergic rhinitis: diminishes nasal congestion caused by allergen exposure.

Nasal decongestant sprays may cause local and systemic reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing or mild itching. - Headache. - Bitter taste. - Transient epistaxis.

Serious or Rare Side Effects: - Rebound congestion (rhinitis medicamentosa) with prolonged use. - Severe hypertension or hypertensive crisis. - Cardiac arrhythmias. - Allergic reactions such as rash, angioedema, or anaphylaxis. - Vision disturbances. - Persistent nasal ulceration.

Before using Nasenspray-Ratiopharm® Erwachsene, consider the following safety measures.

- Do not exceed the recommended frequency: limit to one spray per nostril every 8‑10 hours. - Avoid prolonged use: discontinue after 3 consecutive days to prevent rebound congestion. - Pregnancy and breastfeeding: consult a healthcare professional before use, as safety data are limited. - Age restriction: not intended for children under 12 years of age. - Concomitant cardiovascular disease: use with caution and under medical advice. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medicines, altering its safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Systemic decongestants (e.g., pseudoephedrine): additive vasoconstrictive effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: possible masking of tachycardia. - Other nasal sprays or topical medications: increased local irritation. - Alcohol: may enhance dizziness or drowsiness. - Antihypertensive agents: monitor blood pressure for unexpected changes.